Russian Pharmacy Chain Rankings in Q1 2023

Russian Pharmaceutical Distributor Rankings in Q1 2023

In Q1 2023, Russian manufactures produced 167.6 billion rubles’ worth of ready-made pharmaceutical drugs (manufacturer’s prices, VAT included), down 9.8% from Q1 2022. In physical terms, the production was 0.98 billion packages, down 10.3% from Q1 2022. If calculated in minimum dosage units (MDU), the production went down 3.9%, with 19.1 billion MDUs.

39.6% of physicians think they could leave public healthcare in favor of a private medical institution due to “unjustifiably low salaries”, according to a survey conducted by the RNC Pharma analyst company and the Medvestnik platform for doctors. Another popular reason is “excessive workload and constant overwork”, voted by 31.3% of the respondents.

While most Russian physicians would like to be able to have additional training in a narrower specialty, the options offered by the Ministry of Health are not suitable for 28.9%, according to a survey conducted by the RNC Pharma analyst company and the Medvestnik platform for doctors.

In February 2023, Russian manufacturers produced 100.1 billion rubles’ worth of ready-made pharmaceutical drugs (manufacturer’s prices, VAT included), down 12.6% from February 2022.

In 2022, the online sales or reservations of pharmaceutical products (pharmaceutical drugs and parapharmaceuticals) in Russia were 294.6 billion rubles (end-user prices, VAT included), 40.3% up from 2021, when the growth rate was 53%.

2022 Ranking of Russian Pharmacy Chains.

2022 Ranking of Russian Pharmaceutical Distributors.

In early February, branches of the Social Fund of the Russian Federation began distributing special payments to doctors as part of a government program to support healthcare workers.